William Small

TL;DR: The association with improvement in survival for S100A4-negative patients treated with gemcitabine, although not statistically significant, supports the hypothesis that S 100A4 expression predicts for chemoresistance to gem citabine.

TL;DR: In this article, a practice parameter for high-dose-rate brachytherapy (HDR) is defined, which aims to detail the processes, qualifications of personnel, patient selection, equipment, patient and personnel safety, documentation, and quality control and improvement necessary for an HDR program.

TL;DR: In this paper, the authors investigated skin dose enhancements of brass mesh bolus and a recently developed transparent polymer-gel bolus (PGB) for clinically relevant breast treatment delivery techniques, and concluded that BMB and PGB are clinically equivalent in skin dose enhancement for breast treatment as the 3, 5, and 10 mm tissue-equivalent bolus.

TL;DR: A cylinder applicator with a distal dwell position closer to the apex results in higher doses to the vaginal cuff and increased D2cc to the bladder and additional investigation into applicator design and impact on patient outcomes in larger cohorts with sufficient followup is warranted.